Related Experiment Video

Updated: Jun 13, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

[Role of glycemic control on preventing diabetic macroangiopathy and its therapeutic guidance]

Fuminori Tatsumi1, Kohei Kaku

  • 1Division of Diabetes and Endocrinology, Department of Medicine, Kawasaki Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 8, 2010
PubMed

Insights

Strict glycemic control in diabetes prevents microangiopathy and macroangiopathy. Early intervention is key for preventing diabetic complications, though specific glycemic targets for macroangiopathy remain debated.

Area of Science:

  • Endocrinology
  • Diabetology
  • Clinical Medicine

Background:

  • Glycemic control is linked to diabetic macro- and microangiopathy.
  • Landmark studies (DCCT, Kumamoto, UKPDS) show strict control prevents microangiopathy.
  • Long-term follow-ups (DCCT/EDIC, UKPDS 80) highlight early intervention's importance for macroangiopathy prevention.

Purpose of the Study:

  • To review clinical trials on glycemic control and diabetic macroangiopathy prevention.
  • To discuss the ongoing controversy regarding optimal glycemic targets for macroangiopathy.

Main Methods:

  • Review of recent clinical trials.
  • Analysis of evidence from landmark diabetes studies and their long-term follow-ups.

Main Results:

  • Strict glycemic control effectively prevents microangiopathy.
  • Early intervention significantly contributes to macroangiopathy prevention.
  • The precise glycemic target for preventing diabetic macroangiopathy is still under investigation.

Conclusions:

  • Glycemic control is crucial for preventing both micro- and macrovascular complications in diabetes.
  • Early and sustained glycemic management is vital for long-term patient outcomes.
  • Further research is needed to establish definitive glycemic targets for macroangiopathy prevention.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...